10th international SCWD conference on cachexia, sarcopenia and muscle wasting

 

Dates : 8-10 December 2017
Rome, Italy
Venue: Sheraton Roma Hotel & Conference Center
Official Language: English

Topics

‘Basic Science’ and ‘Clinical Science’ tracks:

  • Cachexia in Cancer, Heart Failure, COPD, CKD and Stroke
  • Sarcopenia, Frailty and the Dysmobility Syndrome
  • Pathophysiology and Epidemiology of Muscle Wasting
  • Body Composition Assessments
  • Screening, Diagnostic and Management
  • Special Populations
  • Clinical Trial Data

Registration prices

  • Medical professionals • 820.00 € (690.00 € until 17 Sept. 2017)
  • Nurses, technicians and doctors <35 years of age • 650.00 € (550.00 € until 17 Sept. 2017)
  • Abstract presenters • 550.00 €
  • Abstract presenters (industry) • 950.00 €
  • Industry representatives • 2 100.00 € (1 600.00 € until 17 Sept. 2017)

Click here for conference registration.

Venue and Hotel

Sheraton Roma Hotel & Conference Center
Viale Del Pattinaggio, 100 , Rome, 00144, Italy

For more information about the venue and accomodation:
Micom srl
Via Bernardino Verro, 12, 20141 Milan, Italy
tel : +390289518895
Email : cachexia@micomevents.com

AIFA (Official Agency for AIFA submissions )

According to Italian legislation, any Marketing Authorisation Holder or pharmaceutical company responsible for the commercialisation of a drug, which organises or helps to organise, whether by direct or indirect funding in Italy or abroad, a congress, or a meeting on topics in any way related to the use of medicines, shall notify the competent Unit of the Italian Medicines Agency (AIFA) at least 60 days before the date of the event to ensure that these adhere to strict technical criteria and aim to provide further knowledge in the fields of chemistry, pharmaceutical technology, biochemistry, physiology, pathology and clinical medicine.

The Official Agency for AIFA submissions (Prerichiesta AIFA) for the 10th International Cachexia Conference is:
Micom srl
Via Bernardino Verro, 12, 20141 Milan, Italy
tel : +390289518895
Email : cachexia@micomevents.com

 

Conference sponsors

Cytokinetics

Hellsinn

Novartis

Smartfish



Stealth biotherapeutics

Dear Colleague,

The Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD) is pleased to invite you to attend its first Updates Programme on Cachexia, Sarcopenia and Wasting Diseases that will be held on December 8-10, 2017, in Rome, Italy.

As an international and multidisciplinary organization, the SCWD seeks to further research on cachexia, sarcopenia and muscle wasting in order to bring practical solutions to healthcare teams worldwide.

Since the first cachexia conference that took place in Berlin in 2000, over 2000 physicians from over 25 countries have attended our educational sessions.

In 2015, 60 international speakers and over 500 participants joined together in Paris. They expressed the need to hold a conference annually. That is the reason why the Board of SCWD organised a rich two-day program in Berlin on December 6-8, 2016 which gathered over 300 participants.

We expect this SCWD updates 2017 to be a unique forum for all medical professionals dealing with muscle wasting in their disciplines and we look forward to meeting you in Rome.

Yours sincerely,

John E. Morley      Stefan D. Anker

International Scientific Committee

Stefan D. Anker (President) – Göttingen, Germany
John E. Morley – St. Louis, USA
William J. Evans – Durham, USA
Akio Inui – Kobe, Japan
Josep M. Argiles – Barcelona, Spain
Filippo Rossi-Fanelli – Rome, Italy
Vickie E. Baracos – Edmonton, Canada
Andrew Coats – Melbourne, Australia and Warwick, UK
Wolfram Doehner – Berlin, Germany
Luigi Ferrucci – Baltimore, USA
David J. Glass – Cambridge, USA
Aminah Jatoi – Rochester, USA
Kamyar Kalantar-Zadeh – Torrance, USA
Florian Strasser – St. Gallen, Switzerland
Stephan von Haehling – Göttingen, Germany

 

Overview on wasting disorders

SCWD articles based on the literature:
Cachexia >
Sarcopenia >
Muscle wasting >

Abstract Submissions

Abstract submissions deadline: 30 July 2017
Late-breaking research and clinical abstract deadline: 30 September 2017
Abstract submission >

 

Educational Objectives

Following this activity, the audience will be able to:
1. Review the latest information about the pathophysiology of muscle wasting and its epidemiology.
2. Screen for and diagnose cachexia, sarcopenia, frailty and dysmobility resulting from the following diseases or chronic conditions: cancer, cardiovascular disease, COPD, CKD, dementia/Alzheimer’s disease, diabetes, infectious diseases, stroke and aging.
3. Develop appropriate management programs for patients across the continuum of care.

 

Target Audience

Internists, oncologists, cardiologists, gerontologists, palliative care specialists, primary care physicians and nurses.